| Huhtaniemi I, White R, McArdle CA, et al.
Will GnRH antagonists improve prostate cancer treatment? [JOURNAL ARTICLE]
Trends Endocrinol Metab 2008 Nov 12.
Abstract | Full Citation |
| Matthews PA
Hormone ablation therapy: lightening the load for today's prostate cancer patient. [Journal Article, Review]
Urol Nurs 2007 Feb.:3-11.
Abstract | Full Citation | Find Related Articles |
| Debruyne F, Bhat G, Garnick MB
Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer. [Journal Article]
Future Oncol 2006 Oct; 2(6):677-96.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Beer TM, Ryan C, Bhat G, et al.
Dose-escalated abarelix in androgen-independent prostate cancer: a phase I study. [Journal Article]
Anticancer Drugs 2006 Oct; 17(9):1075-9.
Abstract | Full Citation | Find Related Articles |
| Trachtenberg J
Emerging pharmacologic therapies for prostate cancer. [Journal Article]
Rev Urol 2001.:S23-8.
Abstract | Full Citation | Find Related Articles |
| Brawer MK
The evolution of hormonal therapy for prostatic carcinoma. [Journal Article]
Rev Urol 2001.:S1-9.
Abstract | Full Citation | Find Related Articles |
| Brawer MK, Crawford ED, Labrie F, et al.
Androgen deprivation and other treatments for advanced prostate cancer. [Journal Article]
Rev Urol 2001.:S59-68.
Abstract | Full Citation | Find Related Articles |
| Beer TM
Experimental use of GnRH antagonists as second-line hormonal therapy. [Journal Article]
Rev Urol 2004.:S33-8.
Abstract | Full Citation | Find Related Articles |
| Debruyne FM
Gonadotropin-releasing hormone antagonist in the management of prostate cancer. [Journal Article]
Rev Urol 2004.:S25-32.
Abstract | Full Citation | Find Related Articles |
| Ye M, Bhat G, Johnston KA, et al.
[JOURNAL ARTICLE]
Expert Opin Drug Deliv 2006 Sep; 3(5):663-675.
Abstract | Full Citation |
  |
